Triflex

Selected form

Method of action: Anti-Inflammatory, Chondroprotective, Restorative

Treatment option: Hypertrophic Osteoarthritis, Osteoarthritis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Triflex

Property	Description
Active Ingredients	Chlorzoxazone, Diclofenac, Paracetamol
Form	Tablet (Oral Administration)
Pharmacological Class	Muscle Relaxant, Nonsteroidal Anti-inflammatory Drug (NSAID), Analgesic
Common Purpose	Relief of Musculoskeletal Pain and Spasm
Origin	Synthetic

Defining Triflex: A Fixed-Dose Combination (FDC) Medicine

Triflex is a synthetic pharmaceutical preparation classified as a fixed-dose combination (FDC), typically administered through the oral route as a tablet. This product is fundamentally defined by its triple component composition, unifying the active ingredients Chlorzoxazone, Diclofenac (or its salt forms), and Paracetamol (Acetaminophen) into a single entity. The FDC structure is a deliberate formulation clinically recognized for its utility in combining multiple therapeutic actions into one convenient form, addressing the complexity of pain and spasm simultaneously. This combination approach is commonly seen in numerous equivalent formulations, which share the same three active ingredients.

Pharmacological Class and Triple Action

The distinct components of Triflex place the product into three primary pharmacological classes, enabling a synergistic triple-action formula. Chlorzoxazone is recognized as a centrally-acting muscle relaxant, acting on the central nervous system to help reduce involuntary muscle spasms and stiffness. The Diclofenac component, classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), acts to reduce pain and inflammation by inhibiting prostaglandin synthesis. Finally, Paracetamol (Acetaminophen) contributes a distinct analgesic and anti-pyretic effect, primarily by raising the overall pain threshold.

General Purpose of the Triflex Formulation

The collective and combined action of these agents determines the general therapeutic purpose of Triflex: the simultaneous relief of discomfort associated with musculoskeletal pain. A typical scenario for its general use involves temporary relief from acute pain accompanying conditions like muscle strain or tension, where both muscle rigidity and inflammation are present. By integrating a component to mitigate painful muscle spasms with agents that reduce localized inflammation and systemic pain sensation, the product offers a comprehensive strategy to alleviate pain where muscle tension and inflammatory responses are co-occurring.

Regulatory References

What side effects are possible with Triflex?

Possible Side Effects and Safety Information

The officially documented safety profile for Triflex, a fixed-dose combination, is structured around the adverse reactions associated with its three components: Chlorzoxazone, Diclofenac, and Paracetamol. These effects are formally classified by official regulatory authorities based on the affected body systems and documented frequency.

Documented Adverse Reaction Categories

Adverse reactions that are frequently listed in regulatory documents as Common include effects on the Nervous System such as drowsiness, dizziness, and headache, as well as Gastrointestinal Disorders like nausea, vomiting, dyspepsia, and abdominal pain. Effects categorized as Rare or Very Rare typically involve more serious concerns.

Serious Adverse Reactions

Regulatory labeling highlights specific adverse reactions that are considered serious due to their clinical impact. These include severe Hepatobiliary Disorders, such as the risk of hepatic failure or severe liver injury, and Gastrointestinal events like bleeding, ulceration, and perforation. The NSAID component is also associated with an increased risk of serious Cardiovascular Thrombotic Events (e.g., myocardial infarction and stroke) and severe Skin Reactions, such as Stevens-Johnson syndrome.

Population-Specific Safety Notes

The official safety information specifies that risks may be increased in certain groups. Older Adults have a documented increased risk for serious gastrointestinal and renal adverse reactions. The medicine is subject to safety constraints and may be contraindicated in individuals with severe hepatic or renal impairment due to the known risks associated with the active components. Furthermore, the NSAID component carries an official restriction for use late in pregnancy.

Safety Constraints and Exposure Patterns

The label notes that the risk of serious cardiovascular events is associated with long-term exposure. Safety limitations also include contraindications for individuals with a history of allergic reactions (e.g., asthma, urticaria) to NSAIDs or aspirin, and a caution regarding the additive sedative effects when used concomitantly with alcohol or other CNS depressants.

Overdose and Emergency Response

Overdose and When to Seek Help

A suspected overdose of Triflex requires immediate emergency medical attention due to the severe and life-threatening risks documented in official regulatory labeling. Overdose presentations are typically a combination of effects. These can include initial non-specific symptoms such as nausea, vomiting, paleness, and profuse sweating, alongside central nervous system effects like severe drowsiness, lightheadedness, and confusion.

The most critical documented outcome is acute liver failure (hepatotoxicity), which is driven by the Paracetamol component. As this damage can be delayed, regulatory guidance mandates that immediate medical assistance be sought, even if the individual remains asymptomatic. Other serious complications listed in regulatory documents include gastrointestinal hemorrhage, ulceration, acute renal failure, and seizures, which are primarily associated with the Diclofenac component.

The required emergency action is to call emergency services or the national Poison Help hotline immediately. Treatment is symptomatic and supportive. A specific antidote, Acetylcysteine, exists for the Paracetamol component and must be administered urgently. Hospital monitoring is required, including the measurement of serum acetaminophen levels and ongoing liver function testing. Official labeling notes that the elderly and individuals with pre-existing hepatic impairment have a greater risk of severe overdose consequences.

Therapeutic Uses of Triflex

Quick Facts on Triflex's Uses

Supports relief from pain associated with muscle spasms.
Used in the management of discomfort linked to musculoskeletal conditions.
May be utilized to help improve muscle movement and flexibility.

What Triflex Treats: Main Uses and Benefits

Triflex is a combination medication used to assist in the management of pain related to muscle spasms. The formulation is applied therapeutically in circumstances where a patient is experiencing painful muscle contractions associated with conditions affecting the body's supporting structures.

Its function is to provide relief from the discomfort and stiffness that accompany these spasms, thereby promoting an improved range of motion and overall physical ease. Triflex is considered an option for individuals who require support in addressing acute musculoskeletal pain. It is also used to manage discomfort and inflammation following certain surgical procedures. The medication's components work to influence the biological processes that contribute to pain signaling and inflammation. A healthcare professional can determine if this therapeutic agent is appropriate for an individual's specific circumstances.

Eligibility and Restrictions for Use

The regulatory eligibility profile for Triflex, a fixed-dose combination, determines who can and cannot use the medicine based on specific health conditions and demographics. The medicine is primarily indicated for use by the Adult Population.

Populations Who Must Not Use the Medicine (Contraindicated)

Absolute non-eligibility applies to several patient groups due to the combined risk factors of its components. The medicine is formally contraindicated in individuals with a known hypersensitivity to any ingredient or to aspirin/other NSAIDs. Additional contraindications include:

Patients with active or recurrent gastrointestinal hemorrhage or peptic ulcers.
Patients with severe hepatic impairment or severe renal disease.
Patients with severe heart disease or those post-Coronary Artery Bypass Graft (CABG) surgery.
Women in the third trimester of pregnancy.

Restricted and Age-Related Use

Use in the Pediatric Population is generally not recommended because safety and efficacy have not been formally established. Use is also not recommended for women who are breastfeeding. Older adults may use the medicine, but caution is advised due to the higher potential for concomitant renal, hepatic, or cardiovascular impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Triflex is a combination medicine, and its interaction profile is defined by the official restrictions for its active components: Chlorzoxazone, Diclofenac, and Paracetamol (Acetaminophen).

Contraindicated and High-Risk Combinations

Other NSAIDs and Paracetamol Products: Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as Ketorolac, is restricted due to an increased risk of severe gastrointestinal events. It is formally contraindicated to take Triflex with any other product containing Paracetamol to prevent the risk of exceeding the maximum dose and causing acute liver failure.
Central Nervous System (CNS) Depressants: Combining the Chlorzoxazone component with other CNS depressants, including alcohol, opioid analgesics, or sedatives, may result in documented additive CNS depression, leading to increased sedation and drowsiness.

Alterations to Drug Levels and Efficacy

Pharmacokinetic Interactions: Co-administration with the potent enzyme inhibitor Voriconazole is documented to increase the plasma concentration of Diclofenac. Furthermore, Diclofenac can reduce the clearance and elevate the plasma levels of both Lithium and Methotrexate.
Antihypertensives: The Diclofenac component may officially reduce the natriuretic and antihypertensive efficacy of Diuretics and ACE inhibitors, effects which are particularly noted in the elderly or those with pre-existing renal impairment.

Mechanism of Action

How Triflex Works: A Triple-Action Mechanistic Overview

The mechanistic profile of this fixed-dose combination arises from the coordinated action of its three components across three distinct biological domains: the periphery, the spinal cord, and the higher brain centers.

️ Inhibition of Prostaglandin Synthesis

This domain covers the action of Diclofenac, which functions primarily by inhibiting Cyclooxygenase (COX) enzymes, especially COX-2, in peripheral tissues. This molecular interaction suppresses the creation of pro-inflammatory mediators. The resulting physiological consequence is decreased peripheral nociceptor sensitization and attenuated local inflammatory signaling.

Central Modulation of Pain Signaling

Paracetamol's mechanism centers on the brain and spinal cord after being metabolized into an active form, which interacts with neural targets like TRPV1 channels and CB1 receptors. This central pathway modulation enhances the activity of the descending inhibitory pathways, resulting in the physiological effect of elevated nociceptive signal processing tolerance.

Depression of Spinal Motor Reflexes

The Chlorzoxazone component acts within the spinal cord and subcortical regions, dampening excitatory activity within the polysynaptic reflex arcs. This action directly intervenes in the nerve signals that maintain muscle hypertonicity, leading to the physiological consequence of dampened efferent motor impulses and modulation of muscle tone.

Dosage and Administration Information

How to Use Triflex: Administration Guidelines

Triflex is a fixed-dose combination (FDC) medication containing Chlorzoxazone, Diclofenac, and Paracetamol. Its administration is based on established prescribing information to ensure standardized use and dosing.

Dosing and Frequency

Instruction	Standard
Route of Administration	Oral (Taken by mouth).
Standard Adult Dose	One tablet per dose.
Frequency and Timing	Two to three times daily (b.i.d. to t.i.d.).
Maximum Use	The maximum intake is typically limited to three tablets per day.

Contextual Administration Rules

Proper use of Triflex involves adherence to specific administration conditions to optimize absorption and reduce potential irritation:

With Food: The tablet must be taken with or immediately after food to help mitigate gastrointestinal discomfort associated with the Diclofenac component.
Swallow Whole: The tablet must be swallowed whole with a liquid. Patients are specifically instructed not to crush, break, or chew the tablet, as this may alter its intended release profile.
Duration: The medicine is intended for use over the shortest duration necessary to manage acute symptoms, aligning with general guidelines for NSAID use.

Population-Specific Use

Dosing caution and possible adjustments are required for certain patient groups, particularly those with hepatic (liver) or renal (kidney) impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Triflex

Evidence for Use in Acute Musculoskeletal Pain Associated with Spasm

The fixed-dose combination of Chlorzoxazone, Diclofenac, and Paracetamol was studied for conditions associated with acute or disruptive episodes of pain, particularly where muscle spasm is involved, such as in cases of acute low back pain. The primary evidence consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews that contribute to the broader evidence landscape for this combination. These research examined outcomes related to physical discomfort and daily functioning or activity level, using tools like pain rating scales and measures of physical flexibility.

Studies conducted during periods of increased symptom activity included adult patients experiencing pain of recent onset. Research highlights changes measured during the study period in these groups, with findings describe patterns observed in the studies related to both pain intensity and muscle stiffness. Some trials described patterns observed when the three-drug combination was evaluated in comparative research scenarios. The reported outcomes were short-term and based on small populations in some cases.

Comparison Research and Study Design

Research exploring short-term symptom changes has compared the three-drug combination to other treatment structures, which can include the individual drug components or dual-drug combinations (such as an NSAID and Paracetamol). The objective of these trials was evaluated in comparative research scenarios, with studies designed to explore outcomes related to the full combination versus dual-drug options.

In these comparative research scenarios, the studies monitored outcomes linked to inflammatory states, as well as those reflecting functional activity. While studies report how symptoms evolved in the observed populations, the data show patterns related to patient-reported outcomes describing perceived discomfort over the defined time intervals.

Evidence Gaps and Areas of Uncertainty

Scientific reviews and regulatory documentation describe areas of research where further study is being explored. One key area of inquiry was studied for involves establishing a clear, documented advantage of the three-drug combination over other established two-drug fixed-dose options. Comparative evidence is lacking in some areas to establish the contribution of the three-drug combination over other formulations in the specific acute musculoskeletal context.

Furthermore, evidence quality varies across studies, and sample sizes were modest in some of the trials exploring short-term changes. These research gaps mean the certainty remains low in some specific comparisons, and research is ongoing to contribute to the broader evidence landscape.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Triflex (FAQ)

Q: What is the difference between the prescription drug Triflex and the joint supplement called TriFlex?

According to regulatory classification, the prescription product Triflex is a fixed-dose combination containing the active drugs Chlorzoxazone, Diclofenac, and Paracetamol. This makes it a prescription medicine and fundamentally different from non-prescription joint supplements, which often contain ingredients like glucosamine or chondroitin.

Q: Does Triflex treat inflammation or just pain?

Official product information indicates the combination is designed to help relieve both pain and inflammation. This dual action is achieved because one of the components, Diclofenac, is a Non-Steroidal Anti-Inflammatory Drug (NSAID) that acts to inhibit pro-inflammatory chemicals in the body.

Q: Is Triflex safe to use during pregnancy, according to official warnings?

Official warnings state the medicine is formally contraindicated (should not be used) during the third trimester of pregnancy. For women who are pregnant or may become pregnant, official guidance states that a healthcare provider should weigh the potential risks and benefits before use.

Q: What happens if I take Triflex with an herbal supplement?

Official warnings require caution when combining this drug with other medications and products. This is particularly true for supplements that cause CNS depression (sedation) or affect how the body processes the medicine. Official guidance recommends disclosing all supplements and products to a healthcare team.

Q: Do studies suggest that the effectiveness of Triflex changes over time?

Regulatory information indicates that the medicine is intended for use over the shortest duration necessary for acute symptoms. Available research supporting its use consists primarily of short-term studies, and the drug is not generally intended for indefinite use.

Q: Does Triflex have an effect on sleep patterns?

The official list of adverse reactions includes common effects on the nervous system such as drowsiness and dizziness. Because of these common side effects, the medicine may consequently affect sleep and alertness.

Q: What information is available regarding the long-term side effects of Triflex?

Official safety information links serious adverse risks, including gastrointestinal problems and cardiovascular events, with long-term exposure to the medication. Official safety information states that the medicine is intended for the shortest duration necessary.

Q: Do I need to avoid operating heavy machinery while taking Triflex?

Official patient information advises caution. Because the medicine commonly causes side effects such as drowsiness and dizziness, patients are advised to use caution when operating machinery or driving. This caution is advised until the effects of the drug on alertness are fully known.

Q: Is Triflex a steroid medicine?

No, Triflex is not a steroid medicine. Regulatory classification identifies the components as a muscle relaxant, a non-steroidal anti-inflammatory drug (NSAID), and an analgesic (pain reliever).

Q: How long does it usually take for Triflex to start working?

Studies on the pharmacokinetics of the muscle relaxant component (Chlorzoxazone) show that it is absorbed rapidly. Blood levels can typically be detected in the blood within the first 30 minutes, with peak concentrations usually reached in 1 to 2 hours after taking the tablet.

Q: Are there any foods or drinks to avoid while using Triflex?

Official documents advise against the consumption of alcohol due to the risk of additive CNS depression, which can cause increased sedation. The tablet is directed to be taken with or immediately after food to help mitigate gastrointestinal discomfort.

Q: Can I take Triflex with my blood thinner medicine?

The Diclofenac component is an NSAID, a class of drugs that may interact with anticoagulants (blood thinners) and potentially increase the risk of bleeding. Official guidance advises close monitoring by a healthcare provider if the drug is used with blood thinners.

Q: What happens in the body when Triflex begins to wear off?

The active components are rapidly metabolized, primarily by the liver. The muscle relaxant component is then mostly excreted in the urine, with less than one percent of the unchanged dose remaining after about 24 hours.

Q: What is the chemical name of the active compound in Triflex?

The active ingredients are Chlorzoxazone, Diclofenac, and Paracetamol. The specific chemical name for the muscle relaxant component (Chlorzoxazone) is 5-Chloro-2-benzoxazolinone.

Q: Can Triflex be taken at the same time as cold or flu medicines?

The official label strictly contraindicates the use of Triflex with any other product containing Paracetamol or other NSAIDs. Since many cold and flu medicines contain these common ingredients, patients should carefully check all labels before combining the medications.

Q: Is the onset of action for Triflex delayed if it is taken with food?

The tablet is specifically directed to be taken with or immediately after food to help mitigate potential gastrointestinal discomfort. Regulatory documents do not state that this administration instruction significantly delays the onset of action.

Q: Is Triflex a federally controlled substance?

No. Official regulatory classification confirms that the active ingredients in this fixed-dose combination are generally not classified as controlled substances under federal schedules.

Q: Has there been any research on combining Triflex with physical therapy?

The muscle relaxant component is officially indicated to be used as an adjunct to rest, physical therapy, and other measures for the relief of discomfort. The official indication means the drug is used as an adjunct (an additional measure) to rest, physical therapy, and other non-drug measures.

Q: Does Triflex contain shellfish or gluten?

Official labeling for the active components does not typically list shellfish. Inactive ingredients for the tablet may include common fillers such as lactose, which is derived from milk. Official labeling suggests that patients with specific allergies should consult the full inactive ingredient list for the dispensed product.

Q: Why is Triflex sometimes prescribed instead of a single-ingredient drug?

The product is a fixed-dose combination (FDC), a deliberate formulation used to combine multiple therapeutic actions into one convenient form. This approach is a deliberate formulation designed to act on simultaneous aspects of discomfort—muscle spasm, pain, and inflammation.

How should Triflex be stored and disposed of?

Storage and Disposal Requirements

Official regulatory labeling dictates the specific conditions required to store and dispose of Triflex tablets (Chlorzoxazone, Diclofenac, Paracetamol) to maintain product stability and safety.

Requirement Category	Official Instruction
Temperature	Store below 30 C (controlled room temperature).
Protection	Protect from light, moisture, and excessive heat.
Packaging Rule	Keep the medicine in the original container, tightly closed.
Child Safety	Keep out of the sight and reach of children.

The product's stability is guaranteed until the printed expiration date, provided these conditions are followed. For disposal, unused or expired medication must be discarded according to local regulatory protocols and pharmaceutical waste instructions. It is explicitly stated that the medicine must not be flushed down the toilet or placed in household trash unless permitted by a specific drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Canada

India

Mexico

Philippines

Singapore

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z